A Prospective study to evaluate the Safety and Efficacy of Investigational Anti-Hair fall shampoo in comparison with Comparator Anti-Hair fall shampoo in subjects with very less to severe Hair fall

Dhathri Ayurveda Pvt Ltd0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Willingness to give written informed consent
•Subjects in the range of 18-50 years of age
•Subjects with very less to severe Hair fall.
•Willingness to discontinue any hair care product other than the IP throughout the study.
•Subjects who are not willing to color their hair throughout the treatment period
•Subjects willing to stop all the hair treatment such as hair spa, straightening, curling, perming, etc.
•Subjects with no skin allergies to any cosmetic products
•Willingness to follow the protocol requirements as evidenced by written informed consent
•Comprehension of the nature and purpose of the study and compliance with the requirement of the entire procedure
•In addition, female subjects selected for the study must be able to use a medically acceptable form of birth control during the study or be surgically sterile or be post-menopausal for at least 1 year.

•1. Subjects with known hypersensitivity to any specific
•ingredients of IPs
•2. Subjects below the age of 18 years and subjects above 50
•3. Subjects not willing to participate in the study
•4. Subjects who have previously undergone hair transplantation
•5. Subjects with any skin diseases.
•6. Subjects are being treated for hair fall or severe active
•infection of any type previously
•7. Presence of any underlying significant uncontrolled medical
•illness involving the cardiovascular, respiratory, renal,
•gastrointestinal, hepatic, immunologic, hematological,endocrine, or nervous system s or psychiatric disease, HIV
•8. Subjects with pre-existing scalp disorder such as scalp
•psoriasis, lichen planus, lichen planopilaris, DLE Discoid
•lupus erythematosus , sebopsoriasis will be excluded from the
•9. A female subject who is breast-feeding, pregnant, or intends
•to become pregnant during the study
•10. Participating in a clinical research trial within 30 days prior to
•11. Subjects who are cognitively impaired and/or who are unable
•to give informed consent.
•12. Any other health or mental condition that in the Investigatorâ??s
•opinion may adversely affect the ability to complete the study
•or its measures or that may pose significant risk to the subject

发起方

Dhathri Ayurveda Pvt Ltd